Patrick A. Ott, MD, PhD | Authors

Treatment for Advanced Melanoma: New Drugs, New Opportunities, New Challenges

May 15, 2013

Remarkably, within 2 years of the introduction of ipilimumab and vemurafenib into the clinic, major new advances have been reported in both the immune checkpoint blockade and small-molecule kinase inhibition arenas.